INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X901. A total of 4 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $318,000 | +23.7% | 100 | -36.7% | 0.06% | +335.7% |
Q1 2017 | $257,000 | -90.4% | 158 | -91.1% | 0.01% | -91.0% |
Q4 2016 | $2,688,000 | +231.0% | 1,781 | +234.1% | 0.16% | +420.0% |
Q3 2016 | $812,000 | -84.8% | 533 | -61.2% | 0.03% | -89.2% |
Q2 2016 | $5,330,000 | +87.9% | 1,373 | +34.6% | 0.28% | +95.8% |
Q1 2016 | $2,836,000 | +427.1% | 1,020 | +920.0% | 0.14% | +373.3% |
Q4 2015 | $538,000 | -90.3% | 100 | -92.7% | 0.03% | -86.8% |
Q3 2015 | $5,518,000 | +51.4% | 1,378 | +20.8% | 0.23% | +70.7% |
Q2 2015 | $3,645,000 | – | 1,141 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 28,000 | $1,303,000 | 0.00% |
JANE STREET GROUP, LLC | 120,900 | $5,625,000 | 0.00% |
SIMPLEX TRADING, LLC | 20,900 | $972,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |